ロード中...

Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA)

Bevacizumab or Avastin® (Av), the recombinant antibody targeting VEGF, improves progression-free but not overall survival of metastatic breast cancer patients due to development of Av resistance. We showed that Av-therapy-induced inflammatory microenvironment contributes to the refractoriness to Av...

詳細記述

保存先:
書誌詳細
出版年:Data Brief
主要な著者: EL-Hajjar, Layal, Shaito, Abdullah, Jalaleddine, Nour, Zibara, Kazem, Kazan, Jalal M., El-Saghir, Jamal, El-Sabban, Marwan
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327074/
https://ncbi.nlm.nih.gov/pubmed/30671510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2018.12.059
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!